Lippincott Journals Subscribers, use your username or email along with your password to log in.
Registered users can save articles, searches, and manage email alerts.
All registration fields are required.
Friend's E-mail is Invalid
Your message has been successfully sent to your friend.
Dr. Rory Spiegel says the EXTEND trial authors created a positive
trial from a negative study, a statistical parlor trick intended to “extend”
the use of IV tPA beyond what is supported by science. (http://bit.ly/2FM63UB.)